Structural basis for the variation in triclosan affinity to enoyl reductases

Journal of Molecular Biology

Volumn 343, Issue 1, 2004, Pages 147-155

  Pidugu, Lakshmi Swarnamukhi ^a   Kapoor, Mili ^a   Surolia, Namita ^b   Surolia, Avadhesha ^a   Suguna, Kaza ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

enoyl ACP reductase; FAS II; NADH; structural comparison; triclosan

Indexed keywords

ENOYL ACYL CARRIER PROTEIN REDUCTASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; OXIDOREDUCTASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; TRICLOSAN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYSTAL STRUCTURE; DRUG BINDING; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME SUBSTRATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; STRUCTURE ANALYSIS;

EID: 4644355051     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2004.08.033     Document Type: Article

References (41)

1. R.J. Heath, S.W. White, and C.O. Rock Lipid biosynthesis as a target for antibacterial agents Prog. Lipid Res. 40 2001 467 497
2. D.J. Payne, P.V. Warren, D.J. Holmes, Y. Ji, and J.T. Lonsdale Bacterial fatty-acid biosynthesis: a genomics-driven target for antibacterial drug discovery Drug Discov. Today 6 2001 537 544
3. A.D. McCarthy, and D.G. Hardie Fatty acid synthase-an example of protein evolution by gene fusion Trends Biochem. Sci. 9 1984 60 63
4. S. Smith The animal fatty acid synthase: one gene, one polypeptide, seven enzymes FASEB J. 8 1994 1248 1259
5. C.O. Rock, and J.E. Cronan Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis Biochim. Biophys. Acta 1302 1996 1 16
6. A. Dessen, A. Quemard, J.S. Blanchard, W.R. Jacobs Jr, and J.C. Sacchettini Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis Science 267 1995 1638 1641
7. D.A. Rozwarski, G.A. Grant, D.H.R. Barton, W.R. Jacobs Jr., and J.C. Sacchettini Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis Science 279 1998 98 102
8. R.F. Waller, P.J. Keeling, R.G. Donald, B. Striepen, E. Handman, and N. Lang-Unnasch Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum Proc. Natl Acad. Sci. USA. 95 1998 12352 12357
9. N. Surolia, S.P. Ramachandra Rao, and A. Surola Paradigm shifts in malaria parasite biochemistry and anti-malarial chemotherapy Bioessays 24 2002 192 196
10. P. Gornicki Apicoplast fatty acid biosynthesis as a target for medical intervention in apicomplexan parasites Int. J. Parasitol. 33 2003 885 896
11. H. Bergler, P. Wallner, A. Ebeling, B. Leitinger, S. Fuchsbichler, and H. Aschauer Protein EnvM is the NADH-dependent enoyl-ACP reductase (FabI) of Escherichia coli J. Biol. Chem. 269 1994 5493 5496
12. R.J. Heath, and C.O. Rock Enoyl-acyl carrier protein reductase (fabI) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli J. Biol. Chem. 270 1995 26538 26542
13. J. Webster Handwashing in a neonatal intensive care nursery: product acceptability and effectiveness of chlorhexidine gluconate 4% and triclosan 1% J. Hosp. Infect. 21 1992 137 141
14. L.M. McMurry, M. Oethinger, and S.B. Levy Triclosan targets lipid synthesis Nature 394 1998 531 532
15. R.J. Heath, Y.T. Yu, M.A. Shapiro, E. Olson, and C.O. Rock Broad-spectrum antimicrobial biocides target the FabI component of fatty acid synthesis J. Biol. Chem. 273 1998 30316 30320
16. W.H. Ward, G.A. Holdgate, S. Rowsell, E.G. McLean, R.A. Pauptit, and E. Clayton Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan Biochemistry 38 1999 12514 12525
17. L.M. McMurry, P.F. McDermott, and S.B. Levy Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan Antimicrob. Agents Chemother. 43 1999 711 713
18. S.L. Parikh, G. Xiao, and P.J. Tonge Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid Biochemistry 39 2000 7645 7650
19. N. Surolia, and A. Surolia Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum Nature Med. 7 2001 167 173
20. R. Perozzo, M. Kuo, A.S. Sidhu, J.T. Valiyaveettil, R. Bittman, and W.R. Jacobs Jr Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase J. Biol. Chem. 277 2002 13106 13114
21. M. Kapoor, C.C. Reddy, M.V. Krishnasastry, N. Surolia, and A. Surolia Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan Biochem. J. 381 2004 719 724
22. X. Qiu, C.A. Janson, R.I. Court, M.G. Smyth, D.J. Payne, and S.S. Abdel-Meguid Molecular basis for triclosan activity involves a flipping loop in the active site Protein Sci. 8 1999 2529 2532
23. + and a C16 fatty acyl substrate J. Biol. Chem. 274 1999 15582 15589
24. J.B. Rafferty, J.W. Simon, C. Baldock, P.J. Artymiuk, P.J. Baker, and A.R. Stuitje Common themes in redox chemistry emerge from the X-ray structure of oilseed rape (Brassica napus) enoyl-acyl carrier protein reductase Structure 3 1995 927 938
25. C. Baldock, J.B. Rafferty, S.E. Sedelnikova, P.J. Baker, A.R. Stuitje, and A.R. Slabas A mechanism of drug action revealed by structural studies of enoyl reductase Science 274 1996 2107 2110
26. A. Roujeinikova, C.W. Levy, S. Rowsell, S. Sedelnikova, P.J. Baker, and C.A. Minshull Crystallographic analysis of triclosan bound to enoyl reductase J. Mol. Biol. 294 1999 527 535
27. M.R. Kuo, H.R. Morbidoni, D. Alland, S.F. Sneddon, B.B. Gourlie, and M.M. Staveski Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data J. Biol. Chem. 278 2003 20851 20859
28. + Biochem. J. 381 2004 725 733
29. C.W. Levy, A. Roujeinikova, S. Sedelnikova, P.J. Baker, A.R. Stuitje, and A.R. Slabas Molecular basis of triclosan activity Nature 398 1999 383 384
30. S. Parikh, D.P. Moynihan, G. Xiao, and P.J. Tonge Roles of tyrosine 158 and lysine 165 in the catalytic mechanism of InhA, the enoyl-ACP reductase from Mycobacterium tuberculosis Biochemistry 38 1999 13623 13634
31. M. Kapoor, M.J. Dar, A. Surolia, and N. Surolia Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors Biochem. Biophys. Res. Commun. 289 2001 832 837
32. Z. Otwinowski, and W. Minor Processing of X-ray diffraction data collected in oscillation mode Methods Enzymol. 276 1997 307 326
33. J. Navaza AMoRe: an automated package for molecular replacement Acta Crystallog. A 50 1994 157 163
34. A.T. Brünger, P.D. Adams, G.M. Clore, W.L. DeLano, P. Gros, and R.W. Grosse-Kunstleve Crystallography and NMR system: a new software suite for macromolecular structure determination Acta Crystllog. D 54 1998 905 921
35. R.A. Laskowski, M.W. MacArthur, D.S. Moss, and J.M. Thornton PROCHECK: a program to check the stereochemical quality of protein structures J. Appl. Crystallog. 26 1993 283 291
36. G.H. Cohen ALIGN: a program to superimpose protein coordinates, accounting for insertions and deletions J. Appl. Crystallog. 30 1997 1160 1161
37. Collaborative Computational Project, Number 4 The CCP4 suite: programs for protein crystallography Acta Crystallog. D 50 1994 760 763
38. T.A. Jones, and M. Kjeldgaard Electron density map interpretation Methods Enzymol. 277 1997 173 230
39. P.J. Kraulis MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures J. Appl. Crystallog. 24 1991 946 950
40. E.A. Merrit, and D.J. Bacon Raster3D: photorealistic molecular graphics Methods Enzymol. 277 1997 505 524
41. R. Esnouf An extensively modified version of MolScript that includes greatly enhanced coloring capabilities J. Mol. Graph. 15 1997 132 134